Compare VCEL & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | GAB |
|---|---|---|
| Founded | 1989 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 1997 | N/A |
| Metric | VCEL | GAB |
|---|---|---|
| Price | $36.47 | $6.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $60.40 | N/A |
| AVG Volume (30 Days) | 592.9K | ★ 667.8K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.91% |
| EPS Growth | ★ 236.54 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $258,716,999.00 | N/A |
| Revenue This Year | $17.86 | N/A |
| Revenue Next Year | $18.55 | N/A |
| P/E Ratio | $148.09 | ★ N/A |
| Revenue Growth | ★ 14.05 | N/A |
| 52 Week Low | $29.24 | $4.56 |
| 52 Week High | $63.00 | $5.88 |
| Indicator | VCEL | GAB |
|---|---|---|
| Relative Strength Index (RSI) | 44.40 | 42.90 |
| Support Level | $35.85 | $6.15 |
| Resistance Level | $42.68 | $6.29 |
| Average True Range (ATR) | 1.54 | 0.07 |
| MACD | -0.34 | -0.01 |
| Stochastic Oscillator | 9.01 | 10.00 |
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.